ExoDxTM Lung (ALK) and ExoDx Prostate IntelliScore (EPI) were designed for the quantification of certain sEV-associated mRNAs as biomarkers for NSCLC and prostate cancer, respectively. The gene discussed is ALK; the disease is non-small cell lung carcinoma.